mg真人,mg真人在线

Xudong Kong

Tenure-track Associate Professor

  • Tel: +86-021 3420 4126
  • Email: xudong.kong@sjtu.edu.cn
  • Address: Building of Biopharm 4D-218, Dongchuan Road 800, Postcode 200030, Minhang District, Shanghai, China
  • Our research focuses on protein and peptide evolution based on phage display and next-generation sequencing technologies.

Education and Research Experience

Education background

  • Jul. 2009 – Apr. 2015               PhD in Biochemical Engineering

                                                       Supervisors: Dr. Prof. Jian-He Xu, Dr. Prof. Jiahai Zhou

                                                       Bioengineering School

                                                       East China University of Science & Technology, China

                                                       Shanghai Institute of Organic Chemistry, China

  • Sep. 2005 – Jun. 2009             BSc in Bioengineering

                                                       Supervisors: Dr. Prof. Jian-He Xu, Dr. Jiang Pan

                                                       Bioengineering School

                                                       East China University of Science & Technology, China

Appointment

  • August 2020 – present            Tenure Track Associate Professor

                                                       School of Life Sciences and Technology

                                                       Shanghai Jiao Tong University, China

  • May 2015 – July 2020             Postdoctoral Scientist

                                                       Supervisor: Dr. Prof. Christian Heinis

                                                       Laboratory of Therapeutic Proteins and Peptides

                                                       Institute of Chemical Sciences and Engineering

                                                       EPFL, Switzerland

Research Interests

Protein fitness landscape analysis

Protein fitness landscape analysis based on phage display and next-generation sequencing techniques.

Development of orally available peptide drugs

Improve bioavailability of peptide drugs by the evolution of peptide stability and permeability.

Selected Publications

  • ?  

    Kong, X.D., Moriya, J., Carle, V., Abriata, L.A., Pojer, F., Heinis, C. De novo development of proteolytically resistant therapeutic peptides for oral administration. Nat. Biomed. Eng., 2020, 4, 560–571.

    ?  

    Kale, S.S.*, Villequey, C.*, Kong, X.D.*, Zorzi, A., Deyle, K., Heinis, C. Cyclization of peptides with two chemical bridges affords large scaffold diversities. Nat. Chem., 2018, 10, 715-723.

    ?  

    Kong, X.D., Yuan, S.G., Li, L., Chen, S., Xu, J.H.# and Zhou, J.# Engineering of an epoxide hydrolase for efficient bioresolution of bulky pharmaco substrates. Proc. Natl. Acad. Sci. USA, 2014, 111, 15717-15722.

    ?  

    Kong, X.D., Ma, Q., Zhou, J.#, Zeng, B.B.# and Xu, J.H.# A smart library of epoxide hydrolase variants and the top hits for synthesis of (S)-beta-blocker precursors. Angew Chem. Int. Ed., 2014, 53, 6641-6644.